 Martin Voskuil
Concepts (284)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Mycobacterium tuberculosis | 50 | 2026 | 318 | 7.270 |
Why?
| | Bacterial Proteins | 33 | 2026 | 968 | 3.360 |
Why?
| | Gene Expression Regulation, Bacterial | 30 | 2024 | 337 | 3.220 |
Why?
| | Tuberculosis | 19 | 2026 | 284 | 3.140 |
Why?
| | Antitubercular Agents | 13 | 2026 | 208 | 2.060 |
Why?
| | Regulon | 11 | 2020 | 34 | 1.790 |
Why?
| | Protein Kinases | 7 | 2016 | 312 | 1.490 |
Why?
| | Burkholderia pseudomallei | 5 | 2015 | 10 | 1.260 |
Why?
| | Mycobacterium | 2 | 2023 | 101 | 1.130 |
Why?
| | Bacteria, Anaerobic | 2 | 2017 | 25 | 0.860 |
Why?
| | Microbial Viability | 5 | 2021 | 83 | 0.810 |
Why?
| | RNA, Ribosomal | 2 | 2021 | 168 | 0.800 |
Why?
| | Oxygen Consumption | 3 | 2014 | 719 | 0.750 |
Why?
| | Anti-Bacterial Agents | 8 | 2025 | 1925 | 0.710 |
Why?
| | Mycobacterium abscessus | 1 | 2023 | 110 | 0.700 |
Why?
| | Protamine Kinase | 2 | 2010 | 8 | 0.630 |
Why?
| | Anti-Infective Agents | 1 | 2023 | 232 | 0.620 |
Why?
| | RNA Precursors | 1 | 2021 | 154 | 0.610 |
Why?
| | RNA, Bacterial | 7 | 2025 | 182 | 0.610 |
Why?
| | Hypoxia | 6 | 2016 | 1199 | 0.600 |
Why?
| | DNA-Binding Proteins | 10 | 2019 | 1482 | 0.590 |
Why?
| | alpha-Amylases | 5 | 2002 | 11 | 0.570 |
Why?
| | Mycobacterium Infections, Nontuberculous | 1 | 2023 | 339 | 0.570 |
Why?
| | Nitric Oxide | 6 | 2024 | 892 | 0.550 |
Why?
| | Tuberculosis, Pulmonary | 5 | 2021 | 127 | 0.500 |
Why?
| | Adaptation, Physiological | 5 | 2023 | 560 | 0.490 |
Why?
| | Bacillus subtilis | 5 | 1998 | 65 | 0.490 |
Why?
| | In Vitro Techniques | 4 | 2015 | 1049 | 0.480 |
Why?
| | Melioidosis | 2 | 2015 | 5 | 0.470 |
Why?
| | Cell Death | 1 | 2017 | 382 | 0.460 |
Why?
| | Anaerobiosis | 7 | 2015 | 65 | 0.440 |
Why?
| | Mycobacterium bovis | 2 | 2020 | 15 | 0.430 |
Why?
| | Cell Membrane | 1 | 2018 | 709 | 0.430 |
Why?
| | Stomach | 1 | 2015 | 111 | 0.420 |
Why?
| | Mice, Inbred BALB C | 9 | 2026 | 1261 | 0.420 |
Why?
| | Genes, Bacterial | 8 | 2016 | 152 | 0.410 |
Why?
| | Acyl-CoA Dehydrogenase | 1 | 2013 | 8 | 0.400 |
Why?
| | Promoter Regions, Genetic | 7 | 2012 | 1247 | 0.390 |
Why?
| | Plasma Gases | 1 | 2013 | 8 | 0.390 |
Why?
| | Chemical Phenomena | 1 | 2013 | 77 | 0.380 |
Why?
| | BCG Vaccine | 3 | 2020 | 27 | 0.370 |
Why?
| | Disinfectants | 1 | 2013 | 45 | 0.370 |
Why?
| | Drug Resistance, Bacterial | 2 | 2015 | 185 | 0.370 |
Why?
| | Hydroxyl Radical | 1 | 2013 | 86 | 0.370 |
Why?
| | Sigma Factor | 5 | 2021 | 47 | 0.360 |
Why?
| | Energy Metabolism | 1 | 2018 | 935 | 0.360 |
Why?
| | Burkholderia mallei | 2 | 2008 | 7 | 0.350 |
Why?
| | Microbial Sensitivity Tests | 7 | 2026 | 365 | 0.350 |
Why?
| | Ceftazidime | 1 | 2011 | 7 | 0.340 |
Why?
| | Homeostasis | 3 | 2017 | 644 | 0.340 |
Why?
| | Cholesterol | 1 | 2013 | 408 | 0.340 |
Why?
| | Trimethoprim, Sulfamethoxazole Drug Combination | 1 | 2011 | 43 | 0.330 |
Why?
| | Antigens, Bacterial | 4 | 2009 | 126 | 0.320 |
Why?
| | Transcription, Genetic | 12 | 2023 | 1454 | 0.320 |
Why?
| | Sputum | 4 | 2021 | 302 | 0.310 |
Why?
| | Mice | 24 | 2026 | 18355 | 0.300 |
Why?
| | Phenotype | 8 | 2025 | 3170 | 0.290 |
Why?
| | Diarylquinolines | 2 | 2025 | 16 | 0.280 |
Why?
| | Genetic Techniques | 1 | 2008 | 66 | 0.280 |
Why?
| | Anion Transport Proteins | 1 | 2008 | 8 | 0.270 |
Why?
| | Virulence | 8 | 2024 | 278 | 0.270 |
Why?
| | Disease Models, Animal | 9 | 2025 | 4568 | 0.270 |
Why?
| | Macrophages | 10 | 2024 | 1507 | 0.260 |
Why?
| | Bacteria | 1 | 2013 | 766 | 0.250 |
Why?
| | Animals | 25 | 2026 | 38097 | 0.240 |
Why?
| | Stress, Physiological | 1 | 2009 | 443 | 0.230 |
Why?
| | DNA, Bacterial | 5 | 2004 | 320 | 0.230 |
Why?
| | Linezolid | 1 | 2025 | 25 | 0.230 |
Why?
| | Alleles | 1 | 2008 | 896 | 0.220 |
Why?
| | Mutation | 8 | 2021 | 4090 | 0.220 |
Why?
| | Nitric Oxide Donors | 2 | 2012 | 19 | 0.220 |
Why?
| | Hydrogen-Ion Concentration | 3 | 2017 | 532 | 0.220 |
Why?
| | Acyl Carrier Protein | 1 | 2024 | 8 | 0.210 |
Why?
| | Electron Transport | 2 | 2017 | 110 | 0.210 |
Why?
| | Interferon-gamma | 6 | 2016 | 784 | 0.210 |
Why?
| | ATP-Binding Cassette Transporters | 2 | 2016 | 117 | 0.200 |
Why?
| | Mycobacterium smegmatis | 1 | 2023 | 14 | 0.200 |
Why?
| | Phosphates | 2 | 2016 | 177 | 0.200 |
Why?
| | Triazenes | 1 | 2003 | 6 | 0.200 |
Why?
| | Adenosine Triphosphate | 2 | 2017 | 500 | 0.200 |
Why?
| | Plasmids | 3 | 2008 | 373 | 0.200 |
Why?
| | Base Sequence | 8 | 2012 | 2171 | 0.190 |
Why?
| | Nitric Oxide Synthase | 1 | 2003 | 234 | 0.190 |
Why?
| | Transcription Initiation Site | 1 | 2002 | 43 | 0.180 |
Why?
| | Oligonucleotide Array Sequence Analysis | 8 | 2009 | 751 | 0.180 |
Why?
| | Enzyme Inhibitors | 1 | 2026 | 821 | 0.180 |
Why?
| | Gene Expression Profiling | 10 | 2023 | 1777 | 0.180 |
Why?
| | Molecular Biology | 2 | 2010 | 58 | 0.170 |
Why?
| | Benchmarking | 1 | 2023 | 191 | 0.170 |
Why?
| | Sequence Deletion | 4 | 2016 | 191 | 0.170 |
Why?
| | Biofilms | 2 | 2020 | 292 | 0.160 |
Why?
| | Ethanol | 1 | 2025 | 631 | 0.160 |
Why?
| | Immunity | 1 | 2021 | 140 | 0.160 |
Why?
| | Copper | 1 | 2021 | 120 | 0.160 |
Why?
| | Nitroimidazoles | 2 | 2025 | 16 | 0.140 |
Why?
| | Hydrogen Peroxide | 4 | 2014 | 335 | 0.140 |
Why?
| | Molecular Sequence Data | 7 | 2012 | 2883 | 0.130 |
Why?
| | Bacillus | 1 | 2017 | 17 | 0.130 |
Why?
| | Cell Respiration | 1 | 2017 | 105 | 0.130 |
Why?
| | Granuloma | 2 | 2016 | 97 | 0.130 |
Why?
| | Proto-Oncogene Proteins c-akt | 1 | 2019 | 440 | 0.130 |
Why?
| | Phosphoenolpyruvate Sugar Phosphotransferase System | 1 | 1996 | 4 | 0.130 |
Why?
| | Drug Therapy, Combination | 3 | 2025 | 1043 | 0.120 |
Why?
| | Humans | 23 | 2026 | 145763 | 0.120 |
Why?
| | Escherichia coli | 2 | 2002 | 835 | 0.120 |
Why?
| | Pyrazinamide | 2 | 2026 | 16 | 0.110 |
Why?
| | Oxygen | 3 | 2017 | 981 | 0.110 |
Why?
| | Isoniazid | 2 | 2026 | 70 | 0.110 |
Why?
| | Colony Count, Microbial | 1 | 2015 | 89 | 0.110 |
Why?
| | Color | 1 | 2015 | 81 | 0.110 |
Why?
| | Nitrites | 1 | 2015 | 88 | 0.110 |
Why?
| | Imipenem | 1 | 2014 | 16 | 0.110 |
Why?
| | Mitomycin | 1 | 2014 | 32 | 0.110 |
Why?
| | NAD | 1 | 2015 | 79 | 0.100 |
Why?
| | Operon | 2 | 2020 | 67 | 0.100 |
Why?
| | Clofazimine | 1 | 2014 | 15 | 0.100 |
Why?
| | Nitrates | 1 | 2015 | 96 | 0.100 |
Why?
| | Transcription Factors | 3 | 2019 | 1736 | 0.100 |
Why?
| | Bronchoalveolar Lavage Fluid | 1 | 2016 | 638 | 0.100 |
Why?
| | Salmonella typhimurium | 1 | 2014 | 188 | 0.090 |
Why?
| | Repressor Proteins | 3 | 2002 | 429 | 0.090 |
Why?
| | Cathelicidins | 1 | 2011 | 40 | 0.080 |
Why?
| | Transcriptome | 3 | 2025 | 1042 | 0.080 |
Why?
| | Vitamin K 2 | 1 | 2010 | 1 | 0.080 |
Why?
| | Female | 13 | 2026 | 79035 | 0.080 |
Why?
| | Electrophoretic Mobility Shift Assay | 2 | 2019 | 88 | 0.080 |
Why?
| | Genetic Complementation Test | 2 | 2008 | 72 | 0.080 |
Why?
| | Polymerase Chain Reaction | 3 | 2010 | 1043 | 0.080 |
Why?
| | Heat-Shock Response | 2 | 2009 | 77 | 0.080 |
Why?
| | Cupriavidus | 1 | 2010 | 3 | 0.080 |
Why?
| | DNA-Directed RNA Polymerases | 2 | 2002 | 62 | 0.080 |
Why?
| | Sequence Analysis, DNA | 1 | 1993 | 778 | 0.080 |
Why?
| | Drug Design | 1 | 2011 | 175 | 0.080 |
Why?
| | Gram-Negative Bacterial Infections | 1 | 2010 | 49 | 0.080 |
Why?
| | Lung | 4 | 2023 | 4116 | 0.080 |
Why?
| | Mice, Inbred C3H | 2 | 2023 | 254 | 0.070 |
Why?
| | Prosthesis-Related Infections | 1 | 2010 | 98 | 0.070 |
Why?
| | Flagella | 1 | 2008 | 27 | 0.070 |
Why?
| | Mutagenesis, Site-Directed | 2 | 2002 | 376 | 0.070 |
Why?
| | Oxidative Stress | 5 | 2014 | 1359 | 0.070 |
Why?
| | RNA, Messenger | 4 | 2016 | 2805 | 0.070 |
Why?
| | Phagosomes | 2 | 2008 | 40 | 0.070 |
Why?
| | Gene Deletion | 1 | 2009 | 392 | 0.070 |
Why?
| | Iron-Sulfur Proteins | 1 | 2008 | 47 | 0.070 |
Why?
| | Genetic Vectors | 1 | 2008 | 335 | 0.060 |
Why?
| | Movement | 1 | 2008 | 293 | 0.060 |
Why?
| | Defibrillators, Implantable | 1 | 2010 | 387 | 0.060 |
Why?
| | Chromosome Mapping | 1 | 2007 | 507 | 0.060 |
Why?
| | Treatment Outcome | 1 | 2021 | 11793 | 0.060 |
Why?
| | Lipid Metabolism | 1 | 2009 | 529 | 0.060 |
Why?
| | Sequence Homology, Nucleic Acid | 2 | 2002 | 157 | 0.060 |
Why?
| | Culture Media | 3 | 2012 | 161 | 0.060 |
Why?
| | Uganda | 2 | 2016 | 90 | 0.060 |
Why?
| | Regulatory Sequences, Nucleic Acid | 2 | 2003 | 92 | 0.060 |
Why?
| | Streptomycin | 1 | 2025 | 18 | 0.060 |
Why?
| | Ethambutol | 1 | 2025 | 27 | 0.050 |
Why?
| | Protein Tyrosine Phosphatases | 1 | 2026 | 167 | 0.050 |
Why?
| | Rifampin | 1 | 2025 | 79 | 0.050 |
Why?
| | Drug Interactions | 1 | 2025 | 405 | 0.050 |
Why?
| | Antigenic Variation | 1 | 2004 | 11 | 0.050 |
Why?
| | High-Throughput Screening Assays | 1 | 2026 | 177 | 0.050 |
Why?
| | Consensus Sequence | 3 | 2002 | 73 | 0.050 |
Why?
| | Lipids | 2 | 2024 | 707 | 0.050 |
Why?
| | Gene Expression | 2 | 2012 | 1478 | 0.050 |
Why?
| | Potassium Permanganate | 1 | 2002 | 3 | 0.050 |
Why?
| | Mice, Inbred Strains | 1 | 2023 | 396 | 0.050 |
Why?
| | DNA Footprinting | 1 | 2002 | 33 | 0.050 |
Why?
| | Cluster Analysis | 1 | 2004 | 501 | 0.050 |
Why?
| | Copper Sulfate | 1 | 2021 | 8 | 0.040 |
Why?
| | Vibrio cholerae | 1 | 2001 | 14 | 0.040 |
Why?
| | Mice, Inbred C57BL | 3 | 2023 | 5992 | 0.040 |
Why?
| | HIV Infections | 1 | 2016 | 3195 | 0.040 |
Why?
| | Crystallins | 1 | 2001 | 61 | 0.040 |
Why?
| | Aconitate Hydratase | 2 | 2012 | 14 | 0.040 |
Why?
| | Time Factors | 2 | 2009 | 7133 | 0.040 |
Why?
| | Transcriptional Activation | 1 | 2002 | 372 | 0.040 |
Why?
| | Models, Genetic | 2 | 2008 | 527 | 0.040 |
Why?
| | Mice, SCID | 1 | 2021 | 369 | 0.040 |
Why?
| | Bacterial Adhesion | 1 | 2020 | 109 | 0.040 |
Why?
| | Threonine | 1 | 2019 | 44 | 0.040 |
Why?
| | Biological Transport | 1 | 2021 | 424 | 0.040 |
Why?
| | Guinea Pigs | 2 | 2010 | 159 | 0.040 |
Why?
| | Iron | 1 | 2002 | 359 | 0.040 |
Why?
| | Cell Line | 4 | 2009 | 2823 | 0.040 |
Why?
| | Protein Conformation | 1 | 2002 | 938 | 0.040 |
Why?
| | Cell Wall | 2 | 2009 | 57 | 0.040 |
Why?
| | Binding Sites | 1 | 2002 | 1311 | 0.040 |
Why?
| | Lactococcus lactis | 1 | 1998 | 2 | 0.040 |
Why?
| | Lactobacillus | 1 | 1998 | 28 | 0.040 |
Why?
| | Cells, Cultured | 3 | 2014 | 4151 | 0.030 |
Why?
| | NADP | 1 | 1998 | 52 | 0.030 |
Why?
| | Gram-Positive Bacteria | 1 | 1998 | 48 | 0.030 |
Why?
| | Corynebacterium | 1 | 1998 | 50 | 0.030 |
Why?
| | T-Lymphocytes | 1 | 2006 | 1997 | 0.030 |
Why?
| | Amino Acid Sequence | 2 | 2012 | 2131 | 0.030 |
Why?
| | Mutagenesis | 1 | 1998 | 194 | 0.030 |
Why?
| | Oxidation-Reduction | 2 | 2012 | 1068 | 0.030 |
Why?
| | Enzyme Repression | 1 | 1996 | 6 | 0.030 |
Why?
| | Signal Transduction | 1 | 2010 | 5223 | 0.030 |
Why?
| | Gambia | 1 | 2016 | 8 | 0.030 |
Why?
| | Gene Order | 1 | 2016 | 29 | 0.030 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 2 | 2012 | 979 | 0.030 |
Why?
| | Cytokines | 1 | 2024 | 2069 | 0.030 |
Why?
| | Streptococcus pneumoniae | 1 | 1998 | 186 | 0.030 |
Why?
| | Adaptation, Biological | 1 | 2016 | 48 | 0.030 |
Why?
| | Nitrogen Oxides | 1 | 2016 | 46 | 0.030 |
Why?
| | Adult | 6 | 2021 | 40872 | 0.030 |
Why?
| | Protein Binding | 3 | 2012 | 2240 | 0.030 |
Why?
| | Phosphorylation | 1 | 2019 | 1708 | 0.030 |
Why?
| | Proton-Motive Force | 1 | 2014 | 8 | 0.030 |
Why?
| | Specimen Handling | 1 | 2016 | 183 | 0.030 |
Why?
| | Point Mutation | 1 | 1995 | 241 | 0.030 |
Why?
| | DNA Mutational Analysis | 1 | 1995 | 410 | 0.030 |
Why?
| | Bacterial Load | 1 | 2014 | 67 | 0.030 |
Why?
| | Necrosis | 1 | 2014 | 244 | 0.020 |
Why?
| | Phosphotransferases | 1 | 2012 | 26 | 0.020 |
Why?
| | Drug Monitoring | 1 | 2016 | 401 | 0.020 |
Why?
| | Nucleotide Motifs | 1 | 2012 | 36 | 0.020 |
Why?
| | Nitroso Compounds | 1 | 2012 | 7 | 0.020 |
Why?
| | Nitric Oxide Synthase Type II | 1 | 2012 | 162 | 0.020 |
Why?
| | Spermine | 1 | 2012 | 29 | 0.020 |
Why?
| | Disulfides | 1 | 2012 | 94 | 0.020 |
Why?
| | Oxidants | 1 | 2012 | 99 | 0.020 |
Why?
| | Oxidoreductases | 1 | 2012 | 91 | 0.020 |
Why?
| | Phagocytes | 1 | 2012 | 80 | 0.020 |
Why?
| | Electrophoresis, Polyacrylamide Gel | 1 | 2012 | 331 | 0.020 |
Why?
| | GTP-Binding Proteins | 1 | 2012 | 153 | 0.020 |
Why?
| | Sequence Homology, Amino Acid | 1 | 2012 | 387 | 0.020 |
Why?
| | Glucose | 1 | 1996 | 1048 | 0.020 |
Why?
| | Drug Resistance, Multiple | 1 | 2011 | 25 | 0.020 |
Why?
| | Cysteine | 1 | 2012 | 211 | 0.020 |
Why?
| | Crystallography, X-Ray | 1 | 2012 | 486 | 0.020 |
Why?
| | Stereoisomerism | 1 | 2011 | 103 | 0.020 |
Why?
| | Antimicrobial Cationic Peptides | 1 | 2011 | 81 | 0.020 |
Why?
| | DNA Probes | 1 | 2010 | 59 | 0.020 |
Why?
| | DNA | 2 | 2012 | 1437 | 0.020 |
Why?
| | Immunity, Innate | 1 | 2016 | 835 | 0.020 |
Why?
| | Hydrophobic and Hydrophilic Interactions | 1 | 2011 | 192 | 0.020 |
Why?
| | Protein Structure, Tertiary | 1 | 2012 | 855 | 0.020 |
Why?
| | Protein Structure, Secondary | 1 | 2011 | 371 | 0.020 |
Why?
| | Amino Acid Substitution | 1 | 2011 | 302 | 0.020 |
Why?
| | Biomarkers | 1 | 2021 | 4302 | 0.020 |
Why?
| | Structure-Activity Relationship | 1 | 2011 | 563 | 0.020 |
Why?
| | Propionates | 1 | 2009 | 39 | 0.020 |
Why?
| | Nucleic Acid Conformation | 1 | 2012 | 723 | 0.020 |
Why?
| | In Situ Hybridization, Fluorescence | 1 | 2010 | 328 | 0.020 |
Why?
| | Hemolysis | 1 | 2011 | 242 | 0.020 |
Why?
| | Hot Temperature | 2 | 2002 | 396 | 0.020 |
Why?
| | Microscopy, Fluorescence | 1 | 2010 | 408 | 0.020 |
Why?
| | NADPH Oxidases | 1 | 2008 | 122 | 0.020 |
Why?
| | Superoxides | 1 | 2008 | 198 | 0.020 |
Why?
| | Models, Molecular | 1 | 2012 | 1599 | 0.020 |
Why?
| | Mice, Knockout | 1 | 2014 | 3130 | 0.020 |
Why?
| | Tuberculin Test | 1 | 2006 | 36 | 0.010 |
Why?
| | Host-Pathogen Interactions | 1 | 2009 | 361 | 0.010 |
Why?
| | Male | 4 | 2021 | 73003 | 0.010 |
Why?
| | Statistics as Topic | 1 | 2006 | 283 | 0.010 |
Why?
| | Cattle | 1 | 2007 | 946 | 0.010 |
Why?
| | Lymphocyte Activation | 1 | 2007 | 1133 | 0.010 |
Why?
| | Gene Targeting | 1 | 2003 | 81 | 0.010 |
Why?
| | Aspartic Acid | 1 | 2003 | 88 | 0.010 |
Why?
| | Diamide | 1 | 2002 | 4 | 0.010 |
Why?
| | Species Specificity | 1 | 2004 | 546 | 0.010 |
Why?
| | Sulfhydryl Reagents | 1 | 2002 | 12 | 0.010 |
Why?
| | Siderophores | 1 | 2002 | 13 | 0.010 |
Why?
| | Genes, Reporter | 1 | 2003 | 277 | 0.010 |
Why?
| | Logistic Models | 1 | 2007 | 2139 | 0.010 |
Why?
| | Sequence Alignment | 1 | 2002 | 362 | 0.010 |
Why?
| | Aerobiosis | 1 | 2001 | 18 | 0.010 |
Why?
| | Sodium Dodecyl Sulfate | 1 | 2001 | 25 | 0.010 |
Why?
| | Models, Biological | 1 | 2008 | 1764 | 0.010 |
Why?
| | Heat-Shock Proteins | 1 | 2001 | 139 | 0.010 |
Why?
| | DNA, Complementary | 1 | 2001 | 273 | 0.010 |
Why?
| | Open Reading Frames | 1 | 2001 | 130 | 0.010 |
Why?
| | Genome, Bacterial | 1 | 2001 | 123 | 0.010 |
Why?
| | Cell Proliferation | 1 | 2006 | 2514 | 0.010 |
Why?
| | Vaccination | 1 | 2007 | 1428 | 0.010 |
Why?
| | Kinetics | 1 | 2001 | 1568 | 0.010 |
Why?
| | Adolescent | 2 | 2007 | 22573 | 0.010 |
Why?
| | Reproducibility of Results | 1 | 2004 | 3416 | 0.010 |
Why?
| | Middle Aged | 2 | 2007 | 36302 | 0.010 |
Why?
| | Child, Preschool | 1 | 2006 | 11868 | 0.010 |
Why?
| | Child | 1 | 2006 | 22739 | 0.000 |
Why?
| | Aged | 1 | 2006 | 26215 | 0.000 |
Why?
|
|
Voskuil's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|